| pubmed-article:21454972 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:21454972 | lifeskim:mentions | umls-concept:C0684249 | lld:lifeskim |
| pubmed-article:21454972 | lifeskim:mentions | umls-concept:C0332174 | lld:lifeskim |
| pubmed-article:21454972 | lifeskim:mentions | umls-concept:C0246415 | lld:lifeskim |
| pubmed-article:21454972 | lifeskim:mentions | umls-concept:C0210657 | lld:lifeskim |
| pubmed-article:21454972 | lifeskim:mentions | umls-concept:C1522326 | lld:lifeskim |
| pubmed-article:21454972 | lifeskim:mentions | umls-concept:C0205179 | lld:lifeskim |
| pubmed-article:21454972 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:21454972 | pubmed:dateCreated | 2011-4-21 | lld:pubmed |
| pubmed-article:21454972 | pubmed:abstractText | Docetaxel and pemetrexed have been validated as therapeutics for previously treated advanced non-small-cell lung cancer (NSCLC), but tolerability is a concern for standard treatment with docetaxel administered once every 3 weeks (tri-weekly 75-mg/m(2) schedule). We conducted this retrospective study to compare the efficacy and toxicity of weekly low-dose docetaxel versus tri-weekly pemetrexed for previously treated advanced NSCLC. | lld:pubmed |
| pubmed-article:21454972 | pubmed:language | eng | lld:pubmed |
| pubmed-article:21454972 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21454972 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:21454972 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21454972 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21454972 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21454972 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21454972 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21454972 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21454972 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:21454972 | pubmed:issn | 1421-9794 | lld:pubmed |
| pubmed-article:21454972 | pubmed:author | pubmed-author:KuoHan-PinHP | lld:pubmed |
| pubmed-article:21454972 | pubmed:author | pubmed-author:LeeKang-YunKY | lld:pubmed |
| pubmed-article:21454972 | pubmed:author | pubmed-author:YuChih-TengCT | lld:pubmed |
| pubmed-article:21454972 | pubmed:author | pubmed-author:LinShu-MinSM | lld:pubmed |
| pubmed-article:21454972 | pubmed:author | pubmed-author:FangYueh-FuYF | lld:pubmed |
| pubmed-article:21454972 | pubmed:author | pubmed-author:ShiehMeng-Hen... | lld:pubmed |
| pubmed-article:21454972 | pubmed:author | pubmed-author:LinTing-YuTY | lld:pubmed |
| pubmed-article:21454972 | pubmed:author | pubmed-author:KuoChih-HsiCH | lld:pubmed |
| pubmed-article:21454972 | pubmed:author | pubmed-author:ChungFu-TsaiF... | lld:pubmed |
| pubmed-article:21454972 | pubmed:author | pubmed-author:FengPo-HaoPH | lld:pubmed |
| pubmed-article:21454972 | pubmed:author | pubmed-author:NiYung-LunYL | lld:pubmed |
| pubmed-article:21454972 | pubmed:author | pubmed-author:LoYun-LunYL | lld:pubmed |
| pubmed-article:21454972 | pubmed:copyrightInfo | Copyright © 2011 S. Karger AG, Basel. | lld:pubmed |
| pubmed-article:21454972 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:21454972 | pubmed:volume | 57 | lld:pubmed |
| pubmed-article:21454972 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:21454972 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:21454972 | pubmed:pagination | 147-55 | lld:pubmed |
| pubmed-article:21454972 | pubmed:meshHeading | pubmed-meshheading:21454972... | lld:pubmed |
| pubmed-article:21454972 | pubmed:meshHeading | pubmed-meshheading:21454972... | lld:pubmed |
| pubmed-article:21454972 | pubmed:meshHeading | pubmed-meshheading:21454972... | lld:pubmed |
| pubmed-article:21454972 | pubmed:meshHeading | pubmed-meshheading:21454972... | lld:pubmed |
| pubmed-article:21454972 | pubmed:meshHeading | pubmed-meshheading:21454972... | lld:pubmed |
| pubmed-article:21454972 | pubmed:meshHeading | pubmed-meshheading:21454972... | lld:pubmed |
| pubmed-article:21454972 | pubmed:meshHeading | pubmed-meshheading:21454972... | lld:pubmed |
| pubmed-article:21454972 | pubmed:meshHeading | pubmed-meshheading:21454972... | lld:pubmed |
| pubmed-article:21454972 | pubmed:meshHeading | pubmed-meshheading:21454972... | lld:pubmed |
| pubmed-article:21454972 | pubmed:meshHeading | pubmed-meshheading:21454972... | lld:pubmed |
| pubmed-article:21454972 | pubmed:meshHeading | pubmed-meshheading:21454972... | lld:pubmed |
| pubmed-article:21454972 | pubmed:meshHeading | pubmed-meshheading:21454972... | lld:pubmed |
| pubmed-article:21454972 | pubmed:meshHeading | pubmed-meshheading:21454972... | lld:pubmed |
| pubmed-article:21454972 | pubmed:meshHeading | pubmed-meshheading:21454972... | lld:pubmed |
| pubmed-article:21454972 | pubmed:meshHeading | pubmed-meshheading:21454972... | lld:pubmed |
| pubmed-article:21454972 | pubmed:meshHeading | pubmed-meshheading:21454972... | lld:pubmed |
| pubmed-article:21454972 | pubmed:year | 2011 | lld:pubmed |
| pubmed-article:21454972 | pubmed:articleTitle | Low-dose weekly docetaxel is as tolerable as pemetrexed in previously treated advanced non-small-cell lung cancer. | lld:pubmed |
| pubmed-article:21454972 | pubmed:affiliation | Department of Thoracic Medicine, Chang Gung Memorial Hospital at Linkou, Chang Gung University, College of Medicine, Taipei, Taiwan, ROC. | lld:pubmed |
| pubmed-article:21454972 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:21454972 | pubmed:publicationType | Comparative Study | lld:pubmed |
